Overview
- 3 inspections across 3 sites are on record.
- 12 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-08-17.
At a glance
Inspections
3
Sites
3
Observations
12
Career since
May 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nexgen Pharma Inc | 17 Aug 2018 | Human Drugs | View 483 → |
| Biogen Inc. | 6 Apr 2017 | Human Drugs | View 483 → |
| Bausch Health US., LLC. | 17 May 2016 | Medical Devices & Rad Health | View 483 → |
Sites inspected
Nexgen Pharma IncIrvine, United States1 insp.
Biogen Inc.Cambridge, United States1 insp.
Bausch Health US., LLC.Bridgewater, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Angela Shepas1 shared
Erik W Koester1 shared
John P Mistler1 shared
Michael Serrano1 shared
David H Smith1 shared
Full investigator report
Get the verbatim findings behind Richard A Abate's 12 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site